SCHEMBL214301

SCHEMBL214301

CCC[C@@H](N)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL352611 1.00
SCHEMBL1003546 1.00
Water SCHEMBL8212960 0.97
Hydrochloric Acid SCHEMBL1864650 0.97
Hydrochloric Acid SCHEMBL1861619 0.97
Hydrochloric Acid SCHEMBL1861313 0.97
SCHEMBL29421382 0.97
Alcohol SCHEMBL8668911 0.97 TSHR (0.46)
Sulfuric Acid SCHEMBL21552194 0.87 TP53 (0.48)
SCHEMBL29020431 0.85 TSHR (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117165542-A Engineered beta-amino alcohol dehydrogenase and its use in chiral (R) -beta-amino alcohol preparation 中山大学 2023-12-05 CN claimed
CN-117126896-A Method for preparing (R) -beta-amino alcohol by racemization removal through biological enzyme method 中山大学 2023-11-28 CN claimed
EP-2928867-B1 PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS HOFFMANN LA ROCHE (CH) 2017-08-09 EP claimed
US-9409866-B2 Pyridine-2-amides useful as CB2 agonists HOFFMANN-LA ROCHE INC. (US) 2016-08-09 US claimed
US-20150344429-A1 PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2015-12-03 US claimed
EP-2928867-A1 PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS F. Hoffmann-La Roche AG (CH) 2015-10-14 EP claimed
WO-2014086805-A1 PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2014-06-12 WO claimed
US-12377100-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2025-08-05 US disclosed
WO-2025133248-A1 DIASTEREOMERIC AMINOALCOHOL AND AMINOETHER SALTS OF 2-[(4R,S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-3,4-DIHYDROQUINAZOLIN-4-YL]ACETIC ACID AND THEIR USE FOR ENANTIOMERIC SEPARATION AIC246 AG & CO. KG (DE) 2025-06-26 WO disclosed
US-20250195524-A1 PYRIMIDO-PYRIDAZINONE COMPOUND AS TOLL-LIKE RECEPTOR AGONIST SHANGHAI VISONPHARMA CO., LTD. (CN) 2025-06-19 US disclosed
US-20250059183-A1 PYRIDINE[4,3-D]PYRIMIDINE COMPOUND AS TLR7/8 AGONIST SHANGHAI VISONPHARMA CO., LTD. (CN) 2025-02-20 US disclosed
EP-4497752-A1 PYRIMIDO-PYRIDAZINONE COMPOUND AS TOLL-LIKE RECEPTOR AGONIST Shanghai Visonpharma Co., Ltd. (CN) 2025-01-29 EP disclosed
CN-118974051-A Pyrimidopyridazinones as Toll-like receptor agonists 上海维申医药有限公司 2024-11-15 CN disclosed
US-20030220358-A1 A1 adenosine receptro antagonists BIOGEN IDEC MA INC. 2003-11-27 US disclosed
US-6605601-B2 Hypotensive agents; cardiovascular disorders BIOGEN, INC. 2003-08-12 US disclosed
WO-2003053370-A2 NOVEL DEVELOPER COMPONENTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-07-03 WO disclosed
US-6444832-B1 OSTEOPOROSIS ESSWEIN ANGELIKA (DE) 2002-09-03 US disclosed
US-20020111333-A1 A1 adenosine receptor antagonists BIOGEN IDEC MA INC. 2002-08-15 US disclosed
EP-0865422-B1 USE OF AMINOALCOHOLDERIVATIVES AS DRUGS, DERIVATIVES AND PROCESS FOR THEIR PREPARATION ROCHE DIAGNOSTICS GMBH (DE) 2001-07-11 EP disclosed
CN-1207724-A Amino alcohol derivs., method of producing said derivs., and medicaments contg. them BOEHRINGER MANNHEIM GMBH (DE) 1999-02-10 CN disclosed